Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001326732-25-000017
Filing Date
2025-02-24
Accepted
2025-02-24 08:04:35
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A xncr-20240331.htm   iXBRL 10-Q/A 1058581
2 EX-31.1 xncr-20240331xexx311.htm EX-31.1 10241
3 EX-31.2 xncr-20240331xexx312.htm EX-31.2 10087
4 EX-32.1 xncr-20240331xexx321.htm EX-32.1 6337
  Complete submission text file 0001326732-25-000017.txt   6842099

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20240331.xsd EX-101.SCH 47220
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xncr-20240331_cal.xml EX-101.CAL 72422
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20240331_def.xml EX-101.DEF 267987
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20240331_lab.xml EX-101.LAB 543902
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20240331_pre.xml EX-101.PRE 440937
74 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20240331_htm.xml XML 1030254
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36182 | Film No.: 25654280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)